These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10139487)

  • 41. [A study of nursing systems in transition in developed countries].
    Kojima M; Horiuchi S; Ota K; Oikawa I; Kaharu C; Nomura M; Toyomasu K; Hatono Y; Kanda K; Tanaka Y
    Seiroka Kango Daigaku Kiyo; 1997; 23():49-68. PubMed ID: 9444242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An inquiry concerning future health care technology: methods and general results.
    Banta HD; Gelijns AC; Griffioen J; Graaff PJ
    Health Policy; 1987; 8(3):251-64. PubMed ID: 10285387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are We Ready for a New Approach to Comparing Coverage and Reimbursement Policies for Medical Nutrition in Key Markets: An ISPOR Special Interest Group Report.
    Perugini M; Johnson TJ; Beume TM; Dong OM; Guerino J; Hu H; Kerr K; Kindilien S; Nuijten M; Ofili TU; Taylor M; Wong A; Freijer K
    Value Health; 2022 May; 25(5):677-684. PubMed ID: 35500942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of economic evaluation in the pricing and reimbursement of medicines.
    Drummond M; Jönsson B; Rutten F
    Health Policy; 1997 Jun; 40(3):199-215. PubMed ID: 10168752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Another special relationship? Interactions between health technology policies and health care systems in the United States and the United Kingdom.
    Sampat B; Drummond M
    J Health Polit Policy Law; 2011 Feb; 36(1):119-39. PubMed ID: 21498797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High tech, low yield: doctors' use of medical innovation.
    Burke G
    J Am Health Policy; 1994; 4(1):48-53. PubMed ID: 10131581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Technology assessment in health care--decision makers and health care providers: what they need to know.
    Durand-Zaleski I; Jolly D
    Health Policy; 1990; 15(1):37-44. PubMed ID: 10106860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What the United States can learn about prevention of teenage pregnancy from other developed countries.
    Dryfoos J
    SIECUS Rep; 1985 Nov; 14(2):1-7. PubMed ID: 12280295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast cancer screening; cost-effective in practice?
    De Koning HJ
    Eur J Radiol; 2000 Jan; 33(1):32-7. PubMed ID: 10674787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integration of economic appraisal and health care policy in a health insurance system; the Dutch case.
    Rutten F; van der Linden JW
    Soc Sci Med; 1994 Jun; 38(12):1609-14. PubMed ID: 8047918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Examples of the influence of evaluation on health policy.
    Durieux P; Viens-Bitker C; Jolly D; Blum-Boisgard C
    Health Policy; 1988; 9(3):325-30. PubMed ID: 10302543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health policy on bone density measurement technology in Sweden and Australia.
    Marshall D; Hailey D; Jonsson E
    Health Policy; 1996 Mar; 35(3):217-28. PubMed ID: 10157399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Health Care Experience and Access Between Young and Older Adults in 11 High-Income Countries.
    Hargreaves DS; Greaves F; Levay C; Mitchell I; Koch U; Esch T; Denny S; Frich JC; Struijs J; Sheikh A
    J Adolesc Health; 2015 Oct; 57(4):413-20. PubMed ID: 26205758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Health technology assessment and its influence on health-care priority setting.
    Oliver A; Mossialos E; Robinson R
    Int J Technol Assess Health Care; 2004; 20(1):1-10. PubMed ID: 15176172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. National health systems in eight countries.
    J Am Pharm Assoc; 1975 Dec; 15(12):699. PubMed ID: 1206198
    [No Abstract]   [Full Text] [Related]  

  • 56. Evaluation and policy considerations in the introduction of extracorporeal membrane oxygenation.
    Hailey DM; Slatyer B
    Health Policy; 1992 Oct; 22(3):287-95. PubMed ID: 10122728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deciding on access and levels of care: a comparison of Canada, Britain, Germany, and the United States.
    Grogan CM
    J Health Polit Policy Law; 1992; 17(2):213-32. PubMed ID: 1500646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland.
    Allen N; Walker SR; Liberti L; Salek S
    Value Health; 2017 Mar; 20(3):320-328. PubMed ID: 28292476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality, innovation, and value for money: NICE and the British National Health Service.
    Pearson SD; Rawlins MD
    JAMA; 2005 Nov; 294(20):2618-22. PubMed ID: 16304076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Technology assessment and knowledge brokering: the case of assisted reproduction in The Netherlands.
    van Kammen J; Jansen CW; Bonsel GJ; Kremer JA; Evers JL; Wladimiroff JW
    Int J Technol Assess Health Care; 2006; 22(3):302-6. PubMed ID: 16984057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.